Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 3/20 | 0.39 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | MAOB | P27338 | 3/20 | 0.37 |
| ▸ | MAOA | P21397 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 3/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | ERN1 | O75460 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | PARP1 | P09874 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28244381 | 0.78 | ALDH1A1 (0.35) | TDP1ALDH1A1CYP2A6TSHRHSD17B10 | |
| SCHEMBL6001561 | 0.77 | ALDH1A1 (0.38) | PTPN1POLBMEN1KMT2AMAPT | |
| SCHEMBL98430 | 0.74 | PTPN1 (0.42) | PTPN1POLBMEN1KMT2AMAOB | |
| SCHEMBL29529441 | 0.74 | ALDH1A1 (0.41) | POLBMAOBMAPTRAB9ASMN1; SMN2 | |
| SCHEMBL27560293 | 0.73 | ALDH1A1 (0.31) | TDP1ALDH1A1CYP2A6TSHRHSD17B10 | |
| SCHEMBL10372125 | 0.73 | MAOA (0.44) | MAOBMAOAMAPTNPC1RAB9A | |
| SCHEMBL28819355 | 0.73 | SRC (0.33) | PTPN1POLBMEN1KMT2AL3MBTL1 | |
| SCHEMBL27626197 | 0.72 | PTPN1 (0.41) | PTPN1POLBMEN1KMT2AMAOB | |
| SCHEMBL6013736 | 0.71 | HSD17B10 (0.33) | PTPN1POLBMEN1KMT2ATDP1 | |
| SCHEMBL10944396 | 0.70 | HSD17B10 (0.37) | MEN1KMT2AMAOBL3MBTL1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 115 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115894459-B | 2-Benzofuran carboxylic acid derivative and preparation method and application thereof | 中国药科大学 | 2025-05-27 | — | — | CN | claimed |
| CN-115894459-A | 2-benzofuran carboxylic acid derivative and preparation method and application thereof | 中国药科大学 | 2023-04-04 | — | — | CN | claimed |
| US-5663029-A | DEVELOPMENT OF LATENT IMAGE, TRANSFERRING TO FORM RECORDING SHEETS, COATING A SUBSTRATE USING POLYMERS | XEROX CORPORATION (US) | 1997-09-02 | — | — | US | claimed |
| CN-115894459-B | 2-Benzofuran carboxylic acid derivative and preparation method and application thereof | 中国药科大学 | 2025-05-27 | — | — | CN | disclosed |
| CN-115894459-B | 2-Benzofuran carboxylic acid derivative and preparation method and application thereof | 中国药科大学 | 2025-05-27 | — | — | CN | disclosed |
| CN-115894459-B | 2-Benzofuran carboxylic acid derivative and preparation method and application thereof | 中国药科大学 | 2025-05-27 | — | — | CN | disclosed |
| CN-117616032-A | Rare earth complex | 东曹株式会社 | 2024-02-27 | — | — | CN | disclosed |
| CN-115894459-A | 2-benzofuran carboxylic acid derivative and preparation method and application thereof | 中国药科大学 | 2023-04-04 | — | — | CN | disclosed |
| CN-115894459-A | 2-benzofuran carboxylic acid derivative and preparation method and application thereof | 中国药科大学 | 2023-04-04 | — | — | CN | disclosed |
| CN-115894459-A | 2-benzofuran carboxylic acid derivative and preparation method and application thereof | 中国药科大学 | 2023-04-04 | — | — | CN | disclosed |
| CN-110183341-A | 1,2- dicarbapentaborane class compound and its synthetic method | 华东师范大学 | 2019-08-30 | — | — | CN | disclosed |
| EP-1140897-A4 | PROTEASE INHIBITORS | SMITHKLINE BEECHAM CORP (US) | 2002-04-03 | — | — | EP | disclosed |
| WO-2002017924-A1 | METHOD OF TREATMENT | SMITHKLINE BEECHAM CORPORATION (GB) | 2002-03-07 | — | — | WO | disclosed |
| EP-1140897-A1 | PROTEASE INHIBITORS | SmithKline Beecham Corporation (US) | 2001-10-10 | — | — | EP | disclosed |
| WO-2001070232-A1 | PROTEASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 2001-09-27 | — | — | WO | disclosed |
| WO-2000039115-A1 | PROTEASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 2000-07-06 | — | — | WO | disclosed |
| US-5866589-A | Alkyl substituted piperadinyl and piperazinyl anti-AIDS compounds | PHARMACIA & UPJOHN COMPANY (US) | 1999-02-02 | — | — | US | disclosed |
| WO-1996018628-A1 | ALKYL SUBSTITUTED PIPERADINYL AND PIPERAZINYL ANTI-AIDS COMPOUNDS | PHARMACIA & UPJOHN COMPANY (US) | 1996-06-20 | — | — | WO | disclosed |
| US-5506245-A | TREATMENT OF INSULIN-RESISTANT AND/OR NON INSULIN-DEPENDENT DIABETES | ADIR ET COMPAGNIE (FR) | 1996-04-09 | — | — | US | disclosed |
| EP-0492136-A2 | Retroviral protease inhibitors derived from 3-chloro-2-chloromethyl-1-propene | AMERICAN CYANAMID COMPANY (US) | 1992-07-01 | — | — | EP | disclosed |